{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:56:35Z","timestamp":1783356995748,"version":"3.54.6"},"reference-count":28,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.1536\/ihj.23-423","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T22:17:35Z","timestamp":1706653055000},"page":"119-127","source":"Crossref","is-referenced-by-count":4,"title":["Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3\/Circ_0078450\/MiR-338-3p\/GATA4 Pathway"],"prefix":"10.1536","volume":"65","author":[{"given":"Kelian","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian Campus)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruozhu","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zhu L, Li C, Liu Q, Xu W, Zhou X. Molecular biomarkers in cardiac hypertrophy. J Cell Mol Med 2019; 23: 1671-7.","DOI":"10.1111\/jcmm.14129"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Winkle AJ, Nassal DM, Shaheen R, <i>et al<\/i>. Emerging therapeutic targets for cardiac hypertrophy. Expert Opin Ther Targets 2022; 26: 29-40.","DOI":"10.1080\/14728222.2022.2031974"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 2018; 15: 387-407.","DOI":"10.1038\/s41569-018-0007-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 2016; 97: 245-62.","DOI":"10.1016\/j.yjmcc.2016.06.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yue L, Sheng S, Yuan M, <i>et al<\/i>. HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1alpha\/PPARalpha pathway in AC16 cells. Cell Biol Int 2023; 47: 1068-80.","DOI":"10.1002\/cbin.12001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ren B, Feng J, Yang N, Guo Y, Chen C, Qin Q. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway. Int Immunopharmacol 2021; 98: 107841.","DOI":"10.1016\/j.intimp.2021.107841"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kumar S, Kumar R, Diksha , Kumari A, Panwar A. Astaxanthin: A super antioxidant from microalgae and its therapeutic potential. J Basic Microbiol 2022; 62: 1064-82.","DOI":"10.1002\/jobm.202100391"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gao HL, Yu XJ, Zhang Y, <i>et al<\/i>. Astaxanthin ameliorates blood pressure in salt-induced prehypertensive rats through ROS\/MAPK\/NF-\u03baB pathways in the hypothalamic paraventricular nucleus. Cardiovasc Toxicol 2021; 21: 1045-57.","DOI":"10.1007\/s12012-021-09695-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Heidari M, Chaboksafar M, Alizadeh M, Sohrabi B, Kheirouri S. Effects of astaxanthin supplementation on selected metabolic parameters, anthropometric indices, sirtuin1 and TNF-alpha levels in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial. Front Nutr 2023; 10: 1104169.","DOI":"10.3389\/fnut.2023.1104169"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Alam MN, Hossain MM, Rahman MM, <i>et al<\/i>. Astaxanthin prevented oxidative stress in heart and kidneys of isoproterenol-administered aged rats. J Diet Suppl 2018; 15: 42-54.","DOI":"10.1080\/19390211.2017.1321078"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Monroy-Ruiz J, Sevilla M\u00c1, Carr\u00f3n R, Montero MJ. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats. Pharmacol Res 2011; 63: 44-50.","DOI":"10.1016\/j.phrs.2010.09.003"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hansen TB, Jensen TI, Clausen BH, <i>et al<\/i>. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384-8.","DOI":"10.1038\/nature11993"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol 2018; 1087: 67-79.","DOI":"10.1007\/978-981-13-1426-1_6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chen YH, Zhong LF, Hong X, <i>et al<\/i>. Integrated analysis of circRNA-miRNA-mRNA ceRNA network in cardiac hypertrophy. Front Genet 2022; 13: 781676.","DOI":"10.3389\/fgene.2022.781676"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. He AT, Liu J, Li F, Yang BB. Targeting circular RNAs as a therapeutic approach: Current strategies and challenges. Signal Transduct Target Ther 2021; 6: 185.","DOI":"10.1038\/s41392-021-00569-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liu BY, Li L, Liu GL, <i>et al<\/i>. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacol Sin 2021; 42: 701-14.","DOI":"10.1038\/s41401-020-0496-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wang HB, Duan MX, Xu M, <i>et al<\/i>. Cordycepin ameliorates cardiac hypertrophy via activating the AMPKalpha pathway. J Cell Mol Med 2019; 23: 5715-27.","DOI":"10.1111\/jcmm.14485"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhang Z, Qiu Y, Li W, <i>et al<\/i>. Astaxanthin alleviates foam cell formation and promotes cholesterol efflux in ox-LDL-induced RAW264.7 cells via CircTPP2\/miR-3073b-5p\/ABCA1 pathway. Molecules 2023; 28.","DOI":"10.3390\/molecules28041701"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cheng Y, Su Y, Wang S, <i>et al<\/i>. Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes (Basel) 2020; 11.","DOI":"10.3390\/genes11080868"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Huang C, Wang R, Lu J, <i>et al<\/i>. MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression. J Clin Lab Anal 2022; 36: e24584.","DOI":"10.1002\/jcla.24584"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Li H, Xu JD, Fang XH, <i>et al<\/i>. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res 2020; 116: 1323-34.","DOI":"10.1093\/cvr\/cvz215"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Song R, Lei H, Feng L, <i>et al<\/i>. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4. J Biol Chem 2021; 297: 101189.","DOI":"10.1016\/j.jbc.2021.101189"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Greco CM, Condorelli G. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nat Rev Cardiol 2015; 12: 488-97.","DOI":"10.1038\/nrcardio.2015.71"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer 2019; 18: 176.","DOI":"10.1186\/s12943-019-1109-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zhang N, Zuo Y, Peng Y, Zuo L. Function of N6-methyladenosine modification in tumors. J Oncol 2021; 2021: 6461552.","DOI":"10.1155\/2021\/6461552"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhang R, Qu Y, Ji Z, <i>et al<\/i>. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221\/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett 2022; 27: 55.","DOI":"10.1186\/s11658-022-00349-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lu P, Xu Y, Sheng ZY, <i>et al<\/i>. De-ubiquitination of p300 by USP12 critically enhances METTL3 expression and Ang II-induced cardiac hypertrophy. Exp Cell Res 2021; 406: 112761.","DOI":"10.1016\/j.yexcr.2021.112761"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Dorn LE, Lasman L, Chen J, <i>et al<\/i>. The N6-Methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation 2019; 139: 533-45.","DOI":"10.1161\/CIRCULATIONAHA.118.036146"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-423\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:11:22Z","timestamp":1706933482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-423\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-423","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"23-423"}}